Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic CancerAlica K Beutel, Sabrina Calderon, Ethan Nghiem, et al.
Plos Biology|July 15, 2021
A cross-institutional analysis of the effects of broadening trainee professional development on research productivityPatrick D Brandt, Susi Sturzenegger Varvayanis, Tracey Baas, et al.
Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Blood|March 12, 2020
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemiaTun Kiat Ko, Asif Javed, Kian Leong Lee, et al.
Leukemia|July 9, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress responseSarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic CancerAlica K Beutel, Sabrina Calderon, Ethan Nghiem, et al.
Plos Biology|July 15, 2021
A cross-institutional analysis of the effects of broadening trainee professional development on research productivityPatrick D Brandt, Susi Sturzenegger Varvayanis, Tracey Baas, et al.
Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Blood|March 12, 2020
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemiaTun Kiat Ko, Asif Javed, Kian Leong Lee, et al.
Leukemia|July 9, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress responseSarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier, et al.
Pageof 11